EUVIMEDEUVIMED entdecken
Crossref

Oxytocin Co Administered With Low-Dose Naltrexone Decreased Excessive and “Relapse” Alcohol Drinking In Mice

Yan Zhou, Angelique Baehr, David C. Zhou, Mary Jeanne Kreek

Journal of Substance Abuse and Alcoholism · 2022

DOI: 10.47739/substanceabuse.1096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Substance Abuse and Alcoholism, 2022. Verfasst von Yan Zhou und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxytocin is a neuropeptide that has potential for the development as an anti-alcoholism treatment. Clinical studies have recently found that intranasal oxytocin treatment reduces alcohol withdrawal symptoms or craving in alcohol-dependent patients with high anxiety. In rodents, activation of oxytocin receptor by systemic or central administration of oxytocin decreases alcohol reward, consumption and cue-induced alcohol seeking behaviors. The neurobiological interaction between oxytocin and mu opioid receptors (MOR) has been well established: MOR agonists or endogenous beta-endorphin inhibit oxytocin release and neuronal activity. Here we explored whether oxytocin under MOR antagonism by naltrexone can enhance the reduction of alcohol intake by oxytocin alone after 3-week excessive alcohol drinking in an intermittent access alcohol (IAA) mouse model or after 1-week abstinence in mouse alcohol deprivation effect (ADE) model. For a genetic control for naltrexone effect, neuronal proopiomelanocortin enhancer (nPE) knockout mice with brain-specific beta-endorphin deficiency were further studied with oxytocin. We found that administration of oxytocin at 0.1 mg/kg [but not 0.01 or 0.03 mg/kg] decreased alcohol intake and preference. When oxytocin co- administered with naltrexone, oxytocin at 0.01-0.03 mg/kg with low doses of naltrexone (0.5 or 1 mg/kg) reduced alcohol drinking more profoundly than the sub-effective doses of oxytocin alone. Alcohol “relapse” in the ADE was prevented by either oxytocin alone or co-administration of oxytocin with naltrexone. The oxytocin effect was confirmed in nPE-/- mice, suggesting independent mechanisms by which oxytocin and naltrexone reduced alcohol drinking. Our study suggests that oxytocin in combination with low-dose naltrexone offers a novel strategy in alcoholism treatment.

Zitieren

APA

Zhou, Y., Baehr, A., Zhou, D. C., & Kreek, M. J. (2022). Oxytocin Co Administered With Low-Dose Naltrexone Decreased Excessive and “Relapse” Alcohol Drinking In Mice. Journal of Substance Abuse and Alcoholism. https://doi.org/10.47739/substanceabuse.1096

Vancouver

Zhou Y, Baehr A, Zhou DC, Kreek MJ. Oxytocin Co Administered With Low-Dose Naltrexone Decreased Excessive and “Relapse” Alcohol Drinking In Mice. Journal of Substance Abuse and Alcoholism. 2022. doi:10.47739/substanceabuse.1096

BibTeX
@article{Zhou2022,
  author = {Zhou, Yan and Baehr, Angelique and Zhou, David C. and Kreek, Mary Jeanne},
  title = {Oxytocin Co Administered With Low-Dose Naltrexone Decreased Excessive and “Relapse” Alcohol Drinking In Mice},
  journal = {Journal of Substance Abuse and Alcoholism},
  year = {2022},
  doi = {10.47739/substanceabuse.1096}
}
Kostenlos starten →